Radnet, Inc. operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Radnet with three other
pharmaceutical manufacturers in North America:
Impax Laboratories, Inc.
sales of $860.47 million
of which 83%
was Impax Generics),
Horizon Pharma PLC
of which 100%
was Food & Drug Administration), and
Phibro Animal Health Corp
of which 63%
was Animal Health).
During the year ended December of 2015, sales at
Radnet were $809.63 million.
increase of 12.8%
versus 2014, when the company's sales were $717.57 million.
This was the fifth consecutive year of sales increases at Radnet
(and since 2010, sales have increased a total of 48%).